Particle.news

Bundibugyo Ebola Outbreak in Eastern Congo Tops 11,000 Cases

Soaring child deaths and fast spread have forced vaccine and antiviral trials into the field despite severe security obstacles.

Overview

  • More than six months into the outbreak, health authorities report over 11,000 cases and more than 5,500 deaths concentrated in eastern provinces of the Democratic Republic of Congo.
  • Children under five have been hit hardest, with 1,207 confirmed cases and 844 deaths, a roughly 70% fatality rate that far exceeds the adult rate.
  • Clinical data show external bleeding in only about 5–10% of confirmed cases, which makes Bundibugyo harder to spot and has left about 70% of patients dying in their communities rather than in treatment centers.
  • Vaccine testing is now under way: an Ervebo trial has started and the Tumaini study has launched to test Ervebo plus two Bundibugyo-specific candidates from Oxford and Moderna that are due to join soon, with preliminary results possible early next year if enrolment succeeds.
  • Response teams say genomic tests show the virus is not rapidly evolving and that isolating symptomatic patients can curb spread, but persistent insecurity, misinformation and access problems are slowing case finding, care and trial enrolment.